Community coalitions have been leading the multisector response to the opioid epidemic in the Unites States. However, with the medicalization of opioid use disorder and changing health care policies, hospitals have moved to the forefront, becoming more active in collaborating with community coalitions. Little is currently known about how community coalitions view and approach collaborating with hospitals despite its importance for understanding and advancing interorganizational approaches to combating the opioid epidemic. Using data from semistructured interviews (n = 119) conducted from November 2019 to January 2020 as part of the HEALing Communities Study (ClinicalTrials.gov: NCT04111939), the authors examined how community coalition members perceive hospital collaborations and explored the opportunities and challenges of these partnerships. They characterized 3 emergent themes: coalition approaches to collaborating with hospitals, barriers to collaboration, and opportunities for sustainable relationships. This new evidence highlights the value that coalitions place on hospital collaborations, as well as mechanisms that may help support ongoing partnerships.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control andPrevention. Drug Overdose Death in theU.S. Top 100,000 Annually. National Center for HealthStatistics; . https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm Accessed January4, 2022.
2.
MattsonCL, TanzLJ, QuinnK, KariisaM, PatelP, DavisNL. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep, 2021; 70:202–207.
3.
FlorenceC, LuoF, RiceK. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend, 2021; 218:108350.
4.
FlorenceC, LuoF, XuL, ZhouC. The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care, 2016; 54:901–906.
5.
FranzB, SkinnerD, KelleherK. Why don't hospitals prioritize substance abuse in their community benefit programming?. J Public Health Manage Pract, 2019; 25:62–68.
6.
ButterfossFD, KeglerMC. A coalition model for community action. In: Minkler M, ed. Community organizing for community building for health and welfare. 3rd ed. New Brunswick, NJ: Rutgers University Press; 2012:21.
7.
ButterfossFD, GoodmanRM, WandersmanA. Community coalitions for prevention and health promotion. Health Educ Res, 1993; 8:315–330.
8.
SavicM, BestD, ManningV, LubmanDI. Strategies to facilitate integrated care for people with alcohol and other drug problems: a systematic review. Subst Abuse Treat Prev Policy, 2017; 12:19.
9.
KohHK, BanthamA, GellerAC, et al.Anchor institutions: best practices to address social needs and social determinants of health. Am J Public Health, 2020; 110:309–316.
10.
National Institute on DrugAbuse. DrugsBrains, and Behavior: The Science ofAddiction. U.S. Department of Health and HumanServices; . https://www.drugabuse.gov/sites/default/files/soa.pdf Accessed January4, 2022.
11.
VolkowND, KoobGF, McLellanAT. Neurobiologic advances from the brain disease model of addiction. Longo DL, ed. N Engl J Med, 2016; 374:363–371.
12.
SkinnerD, GardnerW, KelleherKJ. When hospitals join the community: practical considerations and ethical frameworks. J Health Care Poor Underserved, 2016; 27:1171–1182.
13.
RozierMD.Nonprofit hospital community benefit in the U.S.: a scoping review from 2010 to 2019. Front Public Health, 2020; 8:72.
14.
HiltsKE, YeagerVA, GibsonPJ, HalversonPK, BlackburnJ, MenachemiN. Hospital partnerships for population health: a systematic review of the literature. J Healthc Manag, 2021; 66:170–198.
15.
WalshSL, El-BasselN, JacksonRD, et al.The HEALing (Helping to End Addiction Long-term SM) Communities Study: protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug Alcohol Depend, 2020; 217:108335.
16.
KnudsenHK, DrainoniML, GilbertL, et al.Model and approach for assessing implementation context and fidelity in the HEALing Communities Study. Drug Alcohol Depend, 2020; 217:108330.
17.
Sprague MartinezL, RapkinBD, YoungA, et al.Community engagement to implement evidence-based practices in the HEALing communities study. Drug Alcohol Depend, 2020; 217:108326.
18.
DrainoniML, KnudsenHK, AdamsK, et al.Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention. J Subst Abuse Treat, 2022; 138:108731.
19.
GlasgowRE, HardenSM, GaglioB, et al.RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health, 2019; 7:64.
20.
Skjott LinnebergM, KorsgaardS. Coding qualitative data: a synthesis guiding the novice. QRJ, 2019; 19:259–270.
21.
HsiehHF, ShannonSE. Three approaches to qualitative content analysis. Qual Health Res, 2005; 15:1277–1288.
22.
BowenGA.Naturalistic inquiry and the saturation concept: a research note. Qual Res, 2008; 8:137–152.
23.
WhiteDE, OelkeND, FriesenS. Management of a large qualitative data set: establishing trustworthiness of the data. Int J Qual Methods, 2012; 11:244–258.
24.
AlbertiPM, SuttonKM, BakerM. Changes in teaching hospitals' community benefit spending after implementation of the Affordable Care Act. Acad Med, 2018; 93:1524–1530.
25.
FerdinandAO, Epane´JP, MenachemiN. Community benefits provided by religious, other nonprofit, and for-profit hospitals: a longitudinal analysis 2000–2009. Health Care Manage Rev, 2014; 39:145–153.
26.
TilgnerS, HimesL, AllanT, WasowskiK, BickfordB, BurdenW. Ohio Statewide efforts to align public health/health care population health planning. J Public Health Manage Pract, 2018; 24:S66–S68.
27.
CroninCE, FranzB, GranBK. Hospital community benefit in rural appalachia: one more gap. Rural Sociol, 2021; 86:5–25.
28.
CroninCE, FranzB, PagánJA. Why are some US nonprofit hospitals not addressing opioid misuse in their communities?. Popul Health Manage, 2020; 23:407–413.
29.
WalkerDM, MoraAM, HoganTH, DianaML, McAlearneyAS. Assessing trends in hospital system structures from 2008 to 2015. Med Care, 2018; 56:831–839.
30.
JosephJJ, GloverA, OlayiwolaJN, et al.Mask up: academic-community-government partnerships to advance public health during COVID-19. Popul Health Manage, 2021; 24:430–432.
31.
HartleyDM, BeckAF, SeidM, et al.Multi-sector situational awareness in the COVID-19 pandemic: the Southwest Ohio experience. In: BerubeDM, ed. Pandemic communication and resilience. Risk, systems and decisions. Cham, Switzerland: Springer International Publishing; 2021:265–278.
32.
CroninCE, FranzB, ChoykeK, RodriguezV, GranBK. For-profit hospitals have a unique opportunity to serve as anchor institutions in the U.S. Prev Med Rep, 2021; 22:101372.
33.
MassonCL, SorensenJL, PerlmanDC, et al.Hospital- versus community–based syringe exchange: a randomized controlled trial. AIDS Educ Prev, 2007; 19:97–110.
34.
MieleGM, CatonL, FreeseTE, et al.Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact. J Subst Abuse Treat, 2020; 108:20–25.
35.
CroninCE, FranzB, SkinnerD, HaileZT. Hospitals and substance use disorder services in the time of the opioid epidemic. Health Serv Res, 2019; 54:399–406.
36.
ChristensBD, ButterfossFD, MinklerM, WolffT, FranciscoVT, KeglerMC. Learning from coalitions' efforts to promote equity and justice. Health Educ Behav, 2019; 46(1_suppl):110S–114S.
37.
SharfsteinJM, OlsenY. How not to spend an opioid settlement. JAMA, 2020; 323:1031.
38.
LangfordDJ, GrossJB, DoorenbosAZ, TaubenDJ, LoeserJD, GordonDB. Evaluation of the impact of an online opioid education program for acute pain management. Pain Med, 2020; 21:55–60.
39.
RutkowL, SmithKC, LaiAY, VernickJS, DavisCS, AlexanderGC. Prescription drug monitoring program design and function: a qualitative analysis. Drug Alcohol Depend, 2017; 180:395–400.
40.
LefebvreRC, ChandlerRK, HelmeDW, et al.Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study. Drug Alcohol Depend, 2020; 217:108338.
